Hepatitis B Vaccination for Liver Transplant Recipients in the United States: A National Cohort Study.
Based on the United Network for Organ Sharing database (9/1/2022-6/30/2024), only 59.9% liver transplant recipients were vaccinated against hepatitis B virus. The vaccination rate varied widely by region and other clinicodemographic factors. Multilevel interventions and the utilization of a more immunogenic vaccine may improve vaccination rates in this population.
Authors
- Hashem B. El‐Serag (ORCID: https://orcid.org/0000-0001-5964-7579)
- Rubén Hernáez (ORCID: https://orcid.org/0000-0002-1518-4020)
- Michael A. Shi (ORCID: https://orcid.org/0000-0003-3243-4439)
- Chia‐Yu Chiu (ORCID: https://orcid.org/0000-0002-5241-3435)
- George T. Cholankeril (ORCID: https://orcid.org/0000-0001-5335-8426)
- Tzu-Hao Lee (ORCID: https://orcid.org/0000-0002-2478-3447)
- Fasiha Kanwal (ORCID: https://orcid.org/0000-0001-6715-3966)
- Saira Aijaz Khaderi
- Maria Fernanda Machicao (ORCID: https://orcid.org/0000-0001-7383-950X)
- Ramsey Albahra
- Jeong Han
Institutions
- Michael E. DeBakey VA Medical Center (US)
- Baylor College of Medicine (US)
- University of Colorado Anschutz Medical Campus (US)
- University of Colorado Denver (US)
Publication Details
- Journal
- PubMed
- Published
- 2026-09-29
- DOI
- https://doi.org/10.1093/cid/ciag585
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00